The AGE-RAGE system and diabetic nephropathy.

Area of Science:

• Biomedical Science
• Vascular Biology
• Diabetes Research

Background:

• Diabetic vasculopathy is a complex condition driven by multiple factors.
• Advanced glycation end products (AGE) are key environmental contributors to vascular cell damage in diabetes.
• The receptor for AGE (RAGE) is a major genetic factor mediating AGE-induced vascular derangement.

Purpose of the Study:

• To investigate the molecular mechanisms underlying diabetic vasculopathy.
• To identify potential therapeutic targets for diabetic vascular complications.
• To explore the role of RAGE and its variants in diabetes.

Main Methods:

• Analysis of vascular polysomal poly(A)(+)RNA to identify novel splice variants.
• Utilizing RAGE transgenic mouse models to study diabetic nephropathy and retinopathy.
• Investigating the interaction between AGE ligands and RAGE, including soluble RAGE.

Main Results:

• RAGE ligands were identified as causative agents of vascular derangement.
• RAGE transgenic diabetic mice showed exacerbated nephropathy and retinopathy, preventable by inhibiting AGE formation.
• A novel splice variant, endogenous secretory RAGE (esRAGE), was discovered.
• Endogenous secretory RAGE demonstrated the ability to neutralize AGE effects on endothelial cells.

Conclusions:

• The AGE-RAGE system is a critical player in diabetic vasculopathy.
• Endogenous secretory RAGE shows potential as a protective factor against diabetes-induced vascular injury.
• Targeting the AGE-RAGE pathway presents a promising strategy for managing diabetic complications.